SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,000 | -29.4% | 24,510 | -12.6% | 0.00% | – |
| Q1 2022 | $34,000 | -75.5% | 28,057 | -34.0% | 0.00% | – |
| Q4 2021 | $139,000 | 0.0% | 42,497 | +36.5% | 0.00% | – |
| Q3 2021 | $139,000 | -22.8% | 31,144 | -5.7% | 0.00% | – |
| Q2 2021 | $180,000 | -41.7% | 33,014 | -20.0% | 0.00% | – |
| Q1 2021 | $309,000 | +102.0% | 41,286 | +192.6% | 0.00% | – |
| Q4 2020 | $153,000 | -68.8% | 14,108 | -74.6% | 0.00% | – |
| Q3 2020 | $491,000 | +143.1% | 55,488 | +193.7% | 0.00% | – |
| Q2 2020 | $202,000 | +57.8% | 18,890 | -12.1% | 0.00% | – |
| Q1 2020 | $128,000 | +23.1% | 21,500 | +42.6% | 0.00% | – |
| Q4 2019 | $104,000 | -26.8% | 15,081 | +10.0% | 0.00% | – |
| Q3 2019 | $142,000 | +89.3% | 13,715 | +70.7% | 0.00% | – |
| Q2 2019 | $75,000 | +8.7% | 8,034 | +6.7% | 0.00% | – |
| Q1 2019 | $69,000 | -29.6% | 7,527 | -56.7% | 0.00% | – |
| Q4 2018 | $98,000 | +44.1% | 17,400 | +205.9% | 0.00% | – |
| Q3 2018 | $68,000 | +78.9% | 5,689 | +54.1% | 0.00% | – |
| Q2 2018 | $38,000 | +137.5% | 3,691 | +206.1% | 0.00% | – |
| Q1 2018 | $16,000 | +14.3% | 1,206 | -18.8% | 0.00% | – |
| Q4 2017 | $14,000 | +27.3% | 1,485 | +105.7% | 0.00% | – |
| Q3 2017 | $11,000 | +120.0% | 722 | +131.4% | 0.00% | – |
| Q2 2017 | $5,000 | -61.5% | 312 | -62.1% | 0.00% | – |
| Q1 2017 | $13,000 | +62.5% | 824 | +29.0% | 0.00% | – |
| Q4 2016 | $8,000 | – | 639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |